# Molecular Partners (MOLN) — Analyst Forecast

MOLN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/moln/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 5 | 1 | 0 | 6 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Apr 22, 2026 | HC Wainwright & Co. | Maintained | Buy | $13.00 |
| Mar 16, 2026 | HC Wainwright & Co. | Maintained | Buy | $13.00 |
| Jan 27, 2026 | HC Wainwright & Co. | Initiated Coverage | Buy | $13.00 |
| Dec 8, 2025 | JP Morgan | Maintained | Neutral | $3.75 |
| Sep 3, 2025 | JP Morgan | Maintained | Neutral | $4.00 |
| Mar 11, 2025 | LifeSci Capital | Initiated Coverage | Outperform | $12.00 |
| Dec 5, 2023 | JP Morgan | Maintained | Neutral | $4.50 |

## Frequently Asked Questions

### Is MOLN a buy, sell, or hold?

Analysts covering Molecular Partners currently average a Buy rating: 5 buy, 1 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on MOLN?

On Apr 22, 2026, HC Wainwright & Co. maintained Molecular Partners at Buy with a price target of $13.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).